EU Addresses Complex Clinical Trial Designs In New Guideline
The advent of precision medicine has prompted sponsors to experiment with complex clinical trial designs, which can involve increased operational complexity. A new EU-wide guidance has been issued on the subject to pave the way for a harmonized approach.
You may also be interested in...
New EU-wide guidance describes the factors that sponsors should consider when designing and conducting trials with complex innovative designs.
New approaches in study design and methodology, including master protocol trials, are being adopted by biopharma.
The UK insists there have been no major changes to the clinical trial environment since the country voted to leave the EU more than three years ago. It says the country continues to be an attractive location for clinical research.